Resultado de búsqueda
The aim of the LEGACY (Local radioEmbolization using Glass Microspheres for the Assessment of Tumor Control with Y-90) study was to evaluate objective response rate (ORR) and duration of response (DoR) in patients with solitary unresectable HCC treated with yttrium-90 glass microspheres.
31 de ene. de 2024 · Solitary plasmacytoma of bone (SPB; also called osseous plasmacytoma) is a localized tumor in the bone comprised of a single clone of plasma cells in the absence of other features of MM (ie, anemia, hypercalcemia, kidney impairment, or multiple lytic bone lesions). The diagnosis and management of SPB will be reviewed here.
14 de may. de 2018 · A small proportion of plasma cell neoplasms (approximately 5% to 6%) will manifest as a solitary plasmacytoma, either in bone or in extramedullary tissues. These are of particular interest to radiation oncologists as the standard management with curative intent has been definitive RT.
16 de ene. de 2018 · Solitary plasmacytoma is an infrequent form of plasma cell dyscrasia that presents as a single mass of monoclonal plasma cells, located either extramedullary or intraosseous.
2 de dic. de 2016 · Solitary bone plasmacytoma (SBP) is characterized by a solitary area of lytic bone destruction due to clonal plasma cell proliferation without evidence of systemic disease spread. The greatest risk is the progression to multiple myeloma (MM).
20 de feb. de 2019 · With the advent of new immunomodulatory drugs, proteasome inhibitors, and monoclonal antibodies for the treatment of multiple myeloma, there is great interest as to whether these agents can be incorporated into the treatment of solitary plasmacytomas.
19 de mar. de 2021 · The aim of the LEGACY (Local radioEmbolization using Glass Microspheres for the Assessment of Tumor Control with Y-90) study was to evaluate objective response rate (ORR) and duration of response...
